all news

Wed, 13 May 2026 Business Wire

Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)

Wed, 13 May 2026 Business Wire

Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Mon, 11 May 2026 Yahoo! Finance

OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV Assay

Fri, 8 May 2026 Podimetrics

Podimetrics Named “Best New Monitoring Technology Solution” in 2026 MedTech Breakthrough Awards Program

Thu, 7 May 2026 FierceBiotech

Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Tue, 5 May 2026 BioSpace

QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS

Mon, 4 May 2026 BioSpace

Satellite Bio Announces FDA Rare Pediatric Disease Designation for SB-101 for the Treatment of Urea Cycle Disorders (UCDs)

Sun, 3 May 2026 Associated Press

UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers

Fri, 1 May 2026 Business Wire

TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist

Fri, 24 Apr 2026 PR Newswire

Nomad Health Evolves from Staffing Agency to the AI Operating System for Healthcare Staffing Firms

Wed, 22 Apr 2026 Associated Press

Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting

Fri, 10 Apr 2026 Medical Laboratory Observer

PathAI and MedStar Health enter into partnership to enhance digital pathology

Wed, 8 Apr 2026 Business Wire

Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technolog

Wed, 18 Mar 2026 Business Wire

Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026

Wed, 18 Mar 2026 PR Newswire

Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer

Wed, 4 Mar 2026 GlobeNewswire

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Wed, 4 Mar 2026 Business Wire

Arsenal Medical Announces First Patient Treated with ResQFoam for Life-Threatening Abdominal Bleeding

Tue, 3 Mar 2026 pathai.com

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology

Tue, 24 Feb 2026 BioSpace

QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS

Wed, 18 Feb 2026 Global HR Reporter

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

Wed, 11 Feb 2026 Dewpoint Therapeutics

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

Wed, 4 Feb 2026 Dewpoint Therapeutics

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cance

Wed, 28 Jan 2026 Business Wire

TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics

Mon, 26 Jan 2026 Yahoo! Finance

Primmune Therapeutics Announces Additional Close of Series B Financing

Tue, 20 Jan 2026 Yahoo! Finance

FloQast Hits $200 Million ARR Milestone, Driven by Enterprise Momentum and Adoption of its Auditable AI Agents

Mon, 12 Jan 2026 Associated Press

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection

Mon, 12 Jan 2026 Yahoo! Finance

Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Thu, 8 Jan 2026 Business Wire

EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology

Wed, 7 Jan 2026 ir.cyclerion.com

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126

Tue, 6 Jan 2026 PR Newswire

Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions